Regular Article| Volume 88, ISSUE 2, P130-134, February 2000

Download started.


MnSOD Expression Is Increased in Metastatic Gastric Cancer

      This paper is only available as a PDF. To read, Please Download here.


      Background. Manganese superoxide dismutase (MnSOD) catalyzes the scavenging of superoxide radicals in order to protect cells from the damage caused by reactive oxygen species. Previous studies implicate MnSOD in cancer progression, but its role in gastric cancer metastasis is poorly understood.
      Materials and methods. To determine whether MnSOD expression correlates with gastric cancer metastasis, we compared immunostaining for MnSOD in the primary tumors of gastric cancer patients with (n = 15) and without (n = 9) nodal metastases. These patients were matched for risk factors associated with gastric cancer metastasis, such as tumor site, depth, and grade. MnSOD expression was scored positive (increased) if MnSOD staining of tumor cells was more intense than MnSOD staining in corresponding normal gastric epithelial cells. Statistical analyses were via χ2 test and Fisher's exact test.
      Results. MnSOD expression was increased in 14 of the 15 (93%) metastatic tumors, compared to only 4 of the 9 (44%) nonmetastatic tumors (P = 0.015). There was no significant difference in staining when the two groups were compared based on tumor grade (P = 0.70) or depth of tumor cell invasion (T stage) (P = 0.22).
      Conclusions. MnSOD expression is upregulated in the primary tumors of gastric cancer patients with lymph node metastases. This finding supports an involvement of MnSOD and possibly the reactive oxygen status of the gastric tumor microenvironment in gastric cancer metastasis.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Surgical Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect



        • Oberley L.W.
        • Buettner G.R.
        Role of superoxide dismutase in cancer: A review.
        Cancer Res. 1979; 39: 1141
        • Urano M.
        • Kuroda M.
        • Reynolds R.
        • Oberley T.D.
        • St. Clair D.K.
        Expression of manganese superoxide dismutase reduces tumor control radiation dose: Gene-radiotherapy.
        Cancer Res. 1995; 55: 2490
        • Hirose K.
        • Longo D.L.
        • Oppenheim J.J.
        • Matsushima K.
        Overexpression of mitochondrial manganese superoxide dismutase promotes the survival of tumor cells exposed to interleukin-1, tumor necrosis factor, selected anticancer drugs, and ionizing radiation.
        FASEB J. 1993; 7: 361
        • Safford S.E.
        • Oberley T.D.
        • Urano M.
        • St. Clair D.K.
        Suppression of fibrosarcoma metastasis by elevated expression of manganese superoxide dismutase.
        Cancer Res. 1994; 54: 4261
        • Church S.L.
        • Grant J.W.
        • Ridnour L.A.
        • Oberley L.W.
        • Swanson P.E.
        • Meltzer P.S.
        • Trent J.M.
        Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells.
        Proc. Natl. Acad. Sci. USA. 1993; 90: 3113
        • Satomi A.
        • Murakami S.
        • Hashimoto T.
        • Ishida K.
        • Matsuki M.
        • Sonoda M.
        Significance of superoxide dismutase (SOD) in human colorectal cancer tissue: Correlation with malignant intensity.
        J. Gastroenterol. 1995; 30: 177
        • Izutani R.
        • Katoh M.
        • Asano S.
        • Ohyanagi H.
        • Hirose K.
        Enhanced expression of manganese superoxide dismutase mRNA and increased TNFα mRNA expression by gastric mucosa in gastric cancer.
        World J. Surg. 1996; 20: 228
        • Izutani R.
        • Asano S.
        • Imano M.
        • Kuroda D.
        • Kato M.
        • Ohyanagi H.
        Expression of manganese superoxide dismutase in esophageal and gastric cancers.
        J. Gastroenterol. 1998; 33: 816
        • Oka S.
        • Ogino K.
        • Houbara T.
        • Yoshimura S.
        • Okazaki Y.
        • Takemoto T.
        • Kato N.
        • Iida Y.
        • Uda T.
        An immunohistochemical study of copper, zinc-containing superoxide dismutase detected by a monoclonal antibody in gastric mucosa and gastric cancer.
        Histopathology. 1990; 17: 231
        • Beno I.
        • Volkovova K.
        • Staruchova M.
        Gastric mucosal antioxidant activity in patients at increased risk of gastric cancer.
        Neoplasma. 1993; 40: 315
        • Wei L.K.
        The clinical and laboratory studies of superoxide dismutase activity in the human whole blood with early gastric cancer.
        Free Rad. Res. Comms. 1991; 12–13: 759
        • Arivazhagan S.
        • Kavitha K.
        • Nagini S.
        Erythrocyte lipid peroxidation and antioxidants in gastric cancer patients.
        Cell Biochem. Funct. 1997; 15: 15
        • Grace H.W.
        • Wong W.
        • Goeddel D.B.
        Induction of manganese superoxide dismutase by tumor necrosis factor: Possible protective mechanism.
        Science. 1988; 242: 941
        • Masuda A.
        • Longo D.L.
        • Kobayashi Y.
        • Appera E.
        • Oppenheim J.J.
        • Matsushita K.
        Induction of mitochondrial manganese superoxide dismutase by interleukin 1.
        FASEB J. 1988; 2: 3087
        • Alexander H.R.
        • Kelsen D.G.
        • Tepper J.C.
        Cancer of the stomach.
        in: DeVita Jr., V.T. Hellman S. Rosenberg S.A. Cancer: Principles and Practice of Oncology. Lippincott–Raven, Philadelphia1997: 1021-1054